guest ::
| Home > Publications database > JUNB suppresses distant metastasis by influencing the initial metastatic stage. > print |
| Home > Publications database > JUNB suppresses distant metastasis by influencing the initial metastatic stage. > print |
| 001 | 169894 | ||
| 005 | 20240229133659.0 | ||
| 024 | 7 | _ | |a 10.1007/s10585-021-10108-9 |2 doi |
| 024 | 7 | _ | |a pmid:34282521 |2 pmid |
| 024 | 7 | _ | |a 0262-0898 |2 ISSN |
| 024 | 7 | _ | |a 1573-7276 |2 ISSN |
| 024 | 7 | _ | |a altmetric:110257527 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2021-01628 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Wutschka, Juliane |0 P:(DE-He78)86ebb8b048c77e1c7eff002af09c229f |b 0 |e First author |u dkfz |
| 245 | _ | _ | |a JUNB suppresses distant metastasis by influencing the initial metastatic stage. |
| 260 | _ | _ | |a Dordrecht |c 2021 |b Springer Science + Business Media B.V. |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1642168686_15951 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a DKFZ-ZMBH Alliance / #EA:A100#LA:A100#/ 2021 Aug;38(4):411-423 |
| 520 | _ | _ | |a The complex interactions between cells of the tumor microenvironment and cancer cells are considered a major determinant of cancer progression and metastasis. Yet, our understanding of the mechanisms of metastatic disease is not sufficient to successfully treat patients with advanced-stage cancer. JUNB is a member of the AP-1 transcription factor family shown to be frequently deregulated in human cancer and associated with invasion and metastasis. A strikingly high stromal JUNB expression in human breast cancer samples prompted us to functionally investigate the consequences of JUNB loss in cells of the tumor microenvironment on cancer progression and metastasis in mice. To adequately mimic the clinical situation, we applied a syngeneic spontaneous breast cancer metastasis model followed by primary tumor resection and identified stromal JUNB as a potent suppressor of distant metastasis. Comprehensive characterization of the JUNB-deficient tumor microenvironment revealed a strong influx of myeloid cells into primary breast tumors and lungs at early metastatic stage. In these infiltrating neutrophils, BV8 and MMP9, proteins promoting angiogenesis and tissue remodeling, were specifically upregulated in a JUNB-dependent manner. Taken together, we established stromal JUNB as a strong suppressor of distant metastasis. Consequently, therapeutic strategies targeting AP-1 should be carefully designed not to interfere with stromal JUNB expression as this may be detrimental for cancer patients. |
| 536 | _ | _ | |a 311 - Zellbiologie und Tumorbiologie (POF4-311) |0 G:(DE-HGF)POF4-311 |c POF4-311 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de |
| 650 | _ | 7 | |a Metastasis |2 Other |
| 650 | _ | 7 | |a Transcription factor |2 Other |
| 650 | _ | 7 | |a Tumor microenvironment |2 Other |
| 700 | 1 | _ | |a Kast, Bettina |0 P:(DE-He78)417337e7f94f6e1325a168191cbdc4f1 |b 1 |u dkfz |
| 700 | 1 | _ | |a Sator-Schmitt, Melanie |0 P:(DE-He78)2119821cf3458781f06157c7aeecba8b |b 2 |u dkfz |
| 700 | 1 | _ | |a Appak-Baskoy, Sila |0 P:(DE-He78)ac5b93418fe9d72f17cb5e424ea778b8 |b 3 |
| 700 | 1 | _ | |a Hess, Jochen |0 P:(DE-He78)2e5f34f1c58eda4787a14c9dc139ca5f |b 4 |u dkfz |
| 700 | 1 | _ | |a Sinn, Hans-Peter |b 5 |
| 700 | 1 | _ | |a Angel, Peter |0 P:(DE-He78)f4f068e71e0d87bf0ad51e6214ab84e9 |b 6 |u dkfz |
| 700 | 1 | _ | |a Schorpp-Kistner, Marina |0 P:(DE-He78)b64b20197abce42e40bbc84a22b9ca62 |b 7 |e Last author |u dkfz |
| 773 | _ | _ | |a 10.1007/s10585-021-10108-9 |0 PERI:(DE-600)1496876-9 |n 4 |p 411-423 |t Clinical & experimental metastasis |v 38 |y 2021 |x 1573-7276 |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:169894 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-He78)86ebb8b048c77e1c7eff002af09c229f |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-He78)417337e7f94f6e1325a168191cbdc4f1 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-He78)2119821cf3458781f06157c7aeecba8b |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)ac5b93418fe9d72f17cb5e424ea778b8 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 4 |6 P:(DE-He78)2e5f34f1c58eda4787a14c9dc139ca5f |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 6 |6 P:(DE-He78)f4f068e71e0d87bf0ad51e6214ab84e9 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 7 |6 P:(DE-He78)b64b20197abce42e40bbc84a22b9ca62 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-311 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Zellbiologie und Tumorbiologie |x 0 |
| 913 | 0 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-311 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Signalling pathways, cell and tumor biology |x 0 |
| 914 | 1 | _ | |y 2021 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2021-01-29 |w ger |
| 915 | _ | _ | |a DEAL Springer |0 StatID:(DE-HGF)3002 |2 StatID |d 2021-01-29 |w ger |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CLIN EXP METASTAS : 2019 |d 2021-01-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2021-01-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2021-01-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2021-01-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2021-01-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2021-01-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2021-01-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2021-01-29 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2021-01-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2021-01-29 |
| 915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |d 2021-01-29 |
| 920 | 1 | _ | |0 I:(DE-He78)A100-20160331 |k A100 |l A100 Signaltransduktion/ Wachstumskontrolle |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)E221-20160331 |k E221 |l E221 AG Molekulare Grundlagen von HNO-Tumoren |x 1 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)A100-20160331 |
| 980 | _ | _ | |a I:(DE-He78)E221-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|